BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Hospital Son Llàtzer
Palma, EspañaPublications en collaboration avec des chercheurs de Hospital Son Llàtzer (2)
2021
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- And high-risk myeloma
Blood, Vol. 137, Núm. 1, pp. 49-60
2020
-
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 8, pp. 784-792